Story

The article discusses the growing interest in the potential therapeutic use of psychedelic drugs, such as psilocybin (the active ingredient in magic mushrooms), and the changing attitudes towards their regulation. It highlights the shift in the U.S. Surgeon General's perspective on the matter and the increased research efforts to explore the medical applications of these substances.